BANK OF IRELAND KERNEL CAPITAL VENTURE FUNDS
HIBERGENE CLOSES 6.7M SERIES B FUNDING ROUND
Hibergene
From Left: Dawn Walsh, Marketing Manager, Kernel Capital; Brendan Farrell, CEO, HiberGene Diagnostics and Kevin Healy, Senior Manager, Corporate Banking Ireland, Bank of Ireland.
Cork Ireland, 20 April 2017:

Kernel Capital is delighted to confirm that the Bank of Ireland Kernel Capital Venture Funds investee company HiberGene Diagnostics has secured 6.7m Series B investment. The Bank of Ireland Kernel Capital Funds first invested in Hibergene in 2014 and have participated in this round which was led by Cantor Fitzgerald and includes investment from MedCaptain, and UK-based investors operating through the Enterprise Investment Scheme.

###

For more information please contact:
Dawn Walsh
Kernel Capital
+353 (021) 4928974
Latest News




 
Cork
Belfast
 
Rubicon Rubicon Centre, Rossa Avenue,
Bishopstown, Cork

Tel: +353 (0)21 4928974
Belfast Offices Scottish Provident Building,
7 Donegall Square West, Belfast,
Co. Antrim BT1 6JH

Tel: +44 (0)28 90428367

Kernel Management Partners Limited, trading as Kernel Capital, is regulated by the Central Bank of Ireland.